Kenneth M. Shermock, Ph.D. - Publications

Affiliations: 
2009 Johns Hopkins University, Baltimore, MD 
Area:
Public Health, Pharmacy

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Chang HY, Kitchen C, Bishop MA, Shermock KM, Gudzune KA, Kharrazi H, Weiner JP. Claims-based pharmacy markers for comprehensive medication management program case identification: Validation against concurrent and prospective healthcare costs and utilization. Research in Social & Administrative Pharmacy : Rsap. PMID 35550347 DOI: 10.1016/j.sapharm.2022.04.006  0.686
2022 Kitchen CA, Chang HY, Bishop MA, Shermock KM, Kharrazi H, Weiner JP. Comparing and validating medication complexity from insurance claims against electronic health records. Journal of Managed Care & Specialty Pharmacy. 28: 473-484. PMID 35332787 DOI: 10.18553/jmcp.2022.28.4.473  0.697
2021 Bishop MA, Chang HY, Kitchen C, Weiner JP, Kharrazi H, Shermock KM. Development of measurable criteria to identify and prioritize patients for inclusion in comprehensive medication management programs within primary care settings. Journal of Managed Care & Specialty Pharmacy. 27: 1009-1018. PMID 34337988 DOI: 10.18553/jmcp.2021.27.8.1009  0.716
2020 Chang HY, Kan HJ, Shermock KM, Alexander GC, Weiner JP, Kharrazi H. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not. Journal of Managed Care & Specialty Pharmacy. 26: 1282-1290. PMID 32996394 DOI: 10.18553/jmcp.2020.26.10.1282  0.696
2020 Shermock KM. Questionable impact of Universal Medication Schedule. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 32729613 DOI: 10.1093/Ajhp/Zxaa235  0.332
2020 Smith AJF, Ahern SP, Shermock KM, Feller TT, Hill JD. Assessment of impact of daily huddles and visual displays on medication delivery timeliness in a large academic medical center. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 32620969 DOI: 10.1093/Ajhp/Zxaa210  0.36
2020 Segal JB, Apfel A, Brotman DJ, Shermock KM, Clark JM. Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day Readmission. Journal of Managed Care & Specialty Pharmacy. 26: 296-304. PMID 32105180 DOI: 10.18553/Jmcp.2020.26.3.296  0.387
2019 Yun R, Sciubba DM, Lewin J, Streiff MB, Haut ER, Lau BD, Shermock KM, Kraus PS, Popoola VO, Dalpoas SE. Defects in processes of care for pharmacologic prophylaxis are common among neurosurgery patients who develop in-hospital, post-operative venous thromboembolism (VTE). World Neurosurgery. PMID 31698120 DOI: 10.1016/J.Wneu.2019.10.163  0.305
2019 Tolonen HM, Airaksinen MS, Ruokoniemi P, Hämeen-Anttila K, Shermock KM, Kurki P. Medication safety risks to be managed in national implementation of automatic substitution of biological medicines: a qualitative study. Bmj Open. 9: e032892. PMID 31662405 DOI: 10.1136/Bmjopen-2019-032892  0.347
2018 Merola D, Yong C, Noga SJ, Shermock KM. Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable Chemotherapy. Journal of Managed Care & Specialty Pharmacy. 24: 1019-1026. PMID 30247101 DOI: 10.18553/Jmcp.2018.24.10.1019  0.349
2017 Chang HY, Richards TM, Shermock KM, Elder Dalpoas S, J Kan H, Alexander GC, Weiner JP, Kharrazi H. Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance. Medical Care. PMID 29036011 DOI: 10.1097/Mlr.0000000000000825  0.673
2017 Conway S, Brotman D, Pinto B, Merola D, Feldman L, Miller R, Shermock K. Impact of Displaying Inpatient Pharmaceutical Costs at the Time of Order Entry: Lessons From a Tertiary Care Center. Journal of Hospital Medicine. 12: 639-645. PMID 28786430 DOI: 10.12788/Jhm.2779  0.394
2017 Tyynismaa L, Honkala A, Airaksinen M, Shermock KM, Lehtonen L. Identifying High-alert Medications in a University Hospital by Applying Data From the Medication Error Reporting System. Journal of Patient Safety. PMID 28574956 DOI: 10.1097/Pts.0000000000000388  0.39
2016 Streiff MB, Lau BD, Hobson DB, Kraus PS, Shermock KM, Shaffer DL, Popoola VO, Aboagye JK, Farrow NA, Horn PJ, Shihab HM, Pronovost PJ, Haut ER. The Johns Hopkins Venous Thromboembolism Collaborative: Multidisciplinary team approach to achieve perfect prophylaxis. Journal of Hospital Medicine. 11: S8-S14. PMID 27925423 DOI: 10.1002/Jhm.2657  0.376
2016 Piechowski KL, Elder S, Efird LE, Haut ER, Streiff MB, Lau BD, Kraus PS, Rand CS, Popoola VO, Hobson DB, Farrow NE, Shaffer D, Shermock KM. Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis. Journal of Thrombosis and Thrombolysis. PMID 27209202 DOI: 10.1007/S11239-016-1378-8  0.341
2016 Seal BS, Anderson S, Shermock KM. Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer. Journal of Managed Care & Specialty Pharmacy. 22: 227-35. PMID 27003552 DOI: 10.18553/Jmcp.2016.22.3.227  0.364
2015 Tandon S, Chew M, Eklu-Gadegbeku CK, Shermock KM, Morisky DE. Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Type 2 diabetes patients in sub-Saharan Africa. Diabetes Research and Clinical Practice. PMID 26515909 DOI: 10.1016/J.Diabres.2015.10.001  0.322
2015 Lau BD, Haut ER, Hobson DB, Kraus PS, Maritim C, Austin JM, Shermock KM, Maheshwari B, Allen PX, Almario A, Streiff MB. ICD-9 Code-Based Venous Thromboembolism Performance Targets Fail to Measure Up. American Journal of Medical Quality : the Official Journal of the American College of Medical Quality. PMID 25900895 DOI: 10.1177/1062860615583547  0.324
2015 Seal B, Sullivan SD, Ramsey S, Asche CV, Shermock KM, Sarma S, Zagadailov E, Farrelly E, Eaddy M. Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting. Future Oncology (London, England). 11: 439-47. PMID 25675125 DOI: 10.2217/Fon.14.242  0.338
2015 Wong A, Kraus PS, Lau BD, Streiff MB, Haut ER, Hobson DB, Shermock KM. Patient preferences regarding pharmacologic venous thromboembolism prophylaxis. Journal of Hospital Medicine. 10: 108-11. PMID 25418208 DOI: 10.1002/Jhm.2282  0.4
2015 Zagadailov E, Seal BS, Shermock K, Asche CV, Chang J, Kreilick C, Yao J, Cameron J, Morland K, Eaddy M. Evaluating patterns of care in the treatment of bladder cancer with and without metastases. Journal of Clinical Oncology. 33: e15510-e15510. DOI: 10.1200/Jco.2015.33.15_Suppl.E15510  0.309
2015 Seal BS, Shermock K, Asche CV, Chang J, Tangirala M, Kish JK, Zagadailov E, Eaddy M. Adherence to chemotherapy guidelines for non-metastatic (NM) and metastatic (M) colorectal cancer (CRC). Journal of Clinical Oncology. 33: e14690-e14690. DOI: 10.1200/Jco.2015.33.15_Suppl.E14690  0.349
2015 Shermock K, Asche C, Seal B, Kreilick C, Chang J, Zagadailov E, Kish J, Eaddy M, Xia F. Cost of Care for Gastric Cancer In Patients With and Without Metastases Value in Health. 18: A201. DOI: 10.1016/J.Jval.2015.03.1165  0.328
2014 Pherson EC, Shermock KM, Efird LE, Gilmore VT, Nesbit T, LeBlanc Y, Brotman DJ, Deutschendorf A, Swarthout MD. Development and implementation of a postdischarge home-based medication management service. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 71: 1576-83. PMID 25174018 DOI: 10.2146/Ajhp130764  0.317
2014 Seal B, Sullivan SD, Ramsey SD, Asche CV, Shermock K, Sarma S, Zagadailov EA, Farrelly E, Eaddy M. Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases. Applied Health Economics and Health Policy. 12: 547-57. PMID 25005491 DOI: 10.1007/S40258-014-0101-1  0.314
2014 Haut ER, Garcia LJ, Shihab HM, Brotman DJ, Stevens KA, Sharma R, Chelladurai Y, Akande TO, Shermock KM, Kebede S, Segal JB, Singh S. The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis. Jama Surgery. 149: 194-202. PMID 24195920 DOI: 10.1001/Jamasurg.2013.3970  0.3
2014 Seal BS, Sullivan SD, Ramsey SD, Shermock KM, Ren J, Kreilick C, Boklage S, Valluri S, Sarma S, Asche CV. Systemic therapy for colorectal cancer: patterns of chemotherapy and biologic therapy use in nationally representative US claims database. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 28: 229-36. PMID 24142235 DOI: 10.1007/S40259-013-0073-Y  0.313
2014 Serritella A, Lau BD, Haut ER, Kraus PS, Hobson D, Shaffer D, Popoola VO, Shermock K, Lanzkron S, Streiff MB. An Analysis of VTE Prophylaxis Practice in Oncology Patients after Implementation of a Standardized Mandatory Computerized Clinical Decision Support Tool Blood. 124: 4859-4859. DOI: 10.1182/Blood.V124.21.4859.4859  0.35
2013 Seal BS, Sullivan SD, Ramsey S, Shermock KM, Ren J, Kreilick C, Foltz Boklage SH, Valluri S, Sarma S, Asche CV. Medical costs associated with use of systemic therapy in adults with colorectal cancer. Journal of Managed Care Pharmacy : Jmcp. 19: 461-7. PMID 23806060 DOI: 10.18553/Jmcp.2013.19.6.461  0.388
2013 Kebede S, Prakasa KR, Shermock K, Shihab HM, Brotman DJ, Sharma R, Chelladurai Y, Haut ER, Singh S, Segal JB. A systematic review of venous thromboembolism prophylaxis strategies in patients with renal insufficiency, obesity, or on antiplatelet agents. Journal of Hospital Medicine. 8: 394-401. PMID 23761111 DOI: 10.1002/Jhm.2047  0.321
2013 Zeidan AM, Streiff MB, Lau BD, Ahmed SR, Kraus PS, Hobson DB, Carolan H, Lambrianidi C, Horn PB, Shermock KM, Tinoco G, Siddiqui S, Haut ER. Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events. American Journal of Hematology. 88: 545-9. PMID 23553743 DOI: 10.1002/Ajh.23450  0.339
2013 Seal BS, Kreilick C, Boklage SH, Shermock KM, Asche CV. Treatment patterns and cost for colorectal cancer by line of therapy and metastasis status. Journal of Clinical Oncology. 31: e14658-e14658. DOI: 10.1200/Jco.2013.31.15_Suppl.E14658  0.352
2013 Seal B, Valderrama A, Shermock K, Kreilick C, Boklage S, Asche C. Treatment Patterns And Cost Of Care By Lines Of Treatment For Colorectal Cancer In The Optum Oncology Research Database Value in Health. 16: A135. DOI: 10.1016/J.Jval.2013.03.658  0.305
2012 Carter KL, Streiff MB, Ross PA, Wellman JC, Thomas ML, Kraus PS, Shermock KM. Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital. Journal of Thrombosis and Thrombolysis. 34: 437-45. PMID 22865256 DOI: 10.1007/S11239-012-0781-Z  0.36
2012 Lewin JJ, Ledroux SN, Shermock KM, Thompson CB, Goodwin HE, Mirski EA, Gill RS, Mirski MA. Validity and reliability of the Johns Hopkins Adapted Cognitive Exam for critically ill Patients Critical Care Medicine. 40: 139-144. PMID 21926576 DOI: 10.1097/Ccm.0B013E31822Ef9Fc  0.312
2012 Shermock KM, Sullivan SD, Ramsey SD, Seal BS. Provider mix and costs associated with treatment of patients with bone metastases secondary to prostate cancer. Journal of Clinical Oncology. 30: e15175-e15175. DOI: 10.1200/Jco.2012.30.15_Suppl.E15175  0.34
2012 Lau BD, Haut ER, Maheshwari B, Kraus PS, Hobson D, Carolan H, Shermock K, Almario A, Maritim C, Streiff MB. Hospital-Acquired Venous Thromboembolism (VTE): A Retrospective Consecutive Case Series Blood. 120: 4280-4280. DOI: 10.1182/Blood.V120.21.4280.4280  0.383
2012 Lau BD, Haut ER, Maheshwari B, Almario A, Maritim C, Hobson D, Kraus PS, Shermock K, Carolan H, Streiff MB. Hospital-Acquired DVT/PE As “Never Events”: A Misguided Strategy for Performance Improvement in VTE Prevention. Blood. 120: 3180-3180. DOI: 10.1182/Blood.V120.21.3180.3180  0.352
2012 Seal B, Sullivan S, Ramsey S, Asche C, Shermock K, Sarma S, Farrelly E, Eaddy M. PCN54 Evaluating the Inpatient Hospitalization Costs of Treating Prostate Cancer Patients Value in Health. 15: A217. DOI: 10.1016/J.Jval.2012.03.1171  0.316
2012 Seal B, Ramsey S, Asche C, Sarma S, Sullivan S, Shermock K. PCN53 Patterns of Care and Costs Associated With Treatment of Patients With Bone Metastases Secondary to Prostate Cancer Value in Health. 15: A217. DOI: 10.1016/J.Jval.2012.03.1170  0.315
2012 Valluri S, Sullivan SD, Ramsey S, Asche C, Shermock K, Sarma S, Kreilick C, Foltz-Boklage S, Seal B. PCN47 Medical Expenditures Associated With the Use of Systemic Therapy for Colorectal Cancer in Privately Insured Adults in a Claims Database in the United States Value in Health. 15. DOI: 10.1016/J.Jval.2012.03.1164  0.326
2011 Zeidan AM, Streiff MB, Ahmed S, Kraus PS, Hobson D, Horn PB, Shermock K, Tinoco G, Haut ER. Impact of a Venous Thromboembolism Prophylaxis “Smart Orderset”: Improved Compliance, Fewer Events Blood. 118: 172-172. DOI: 10.1182/Blood.V118.21.172.172  0.356
2008 Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Impact of an inpatient anticoagulation management service on clinical outcomes Annals of Pharmacotherapy. 42: 777-782. PMID 18460587 DOI: 10.1345/Aph.1L027  0.356
2008 Shermock KM, Horn E, Rice TL. Erythropoietic agents for anemia of critical illness. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 65: 540-6. PMID 18319499 DOI: 10.2146/Ajhp070225  0.338
2008 Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 65: 145-9. PMID 18192260 DOI: 10.2146/Ajhp070012  0.344
2003 Shen B, Shermock KM, Fazio VW, Achkar JP, Brzezinski A, Bevins CL, Bambrick ML, Remzi FH, Lashner BA. A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis. The American Journal of Gastroenterology. 98: 2460-7. PMID 14638349 DOI: 10.1016/S0002-9270(03)00716-0  0.315
2003 Gildea TR, Shermock KM, Singer ME, Stoller JK. Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. American Journal of Respiratory and Critical Care Medicine. 167: 1387-92. PMID 12574076 DOI: 10.1164/Rccm.200209-1035Oc  0.302
2002 Fuller MA, Shermock KM, Secic M, Laich JS, Durkin MB. Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine. Psychiatric Services (Washington, D.C.). 53: 855-60. PMID 12096169 DOI: 10.1176/Appi.Ps.53.7.855  0.321
2002 Shermock K, Shen B, Lashner B, Achkar J. Pgi8 A Cost Analysis Of Diagnostic And Treatment Strategies In Patients With Symptoms Of Pouchitis Value in Health. 5: 253. DOI: 10.1016/S1098-3015(10)61129-1  0.302
2001 Nesbit TW, Shermock KM, Bobek MB, Capozzi DL, Flores PA, Leonard MC, Long JK, Militello MA, White DA, Barone LD, Goldman MP, Kvancz DA. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 58: 784-90. PMID 11351918 DOI: 10.1093/Ajhp/58.9.784  0.362
2001 Shermock KM, Sadik MK, Kozma CM, Sesti A, Reeder CE. Risperidone, Haloperidol and Clozapine in the South Carolina Medicaid Program A Comparative Analysis of Utilisation and Expenditure Disease Management & Health Outcomes. 9: 203-213. DOI: 10.2165/00115677-200109040-00003  0.342
2001 Shermock K, Fuller M, Secic M, Laich J, Durkin M. Pmh9: Health Care Utilization And Costs In Schizophrenic Patients Taking Risperidone Versus Olanzapine In A Veterans Administration Population Value in Health. 4: 142. DOI: 10.1046/J.1524-4733.2001.40202-195.X  0.385
Show low-probability matches.